Lipid Metabolism

Abnormal lipid profiles are shown by patients with polygenic disorders as hormone regulates several steps of lipid metabolism. Patients suffering with Type1 diabetes show adequate glycaemic control but do not have quantitative lipoprotein abnormalities. Studies shows that patients with both type 1 and type 2diabetes have consistent weight gain, exhibited more lipid profiles in Type2 diabetes (T2D). Dyslipidaemia in Type2 diabetes has shown many strictly linked abnormalities.

  • Diabetes control and complications
  • Hyperglycemia and insulin resistance
  • Dyslipidemia

Related Conference of Lipid Metabolism

July 29-30, 2025

15th World Congress on Endocrinology and Diabetes

Paris, France
September 08-09, 2025

3rd World congress and Expo on Diabetes

Frankfurt, Germany
October 27-28, 2025

5th World Congress on Endocrine and Diabetes

Madrid, Spain
October 30-31, 2025

5th Annual Summit on Diabetes and Endocrinology

Paris, France
November 03-04, 2025

34th European Diabetes Congress

Rome, Italy
November 06-07, 2025

8th Annual Meeting on Diabetes and Endocrinology

Dubai, UAE
November 20-21, 2025

21st World Congress on Endocrinology & Diabetes

Paris, France
November 24-25, 2025

6th International conference on Diabetic complications

Barcelona, Spain
February 23-24, 2026

19th International Summit on Diabetes

London, UK
March 26-27, 2026

7th Global summit on Diabetes and Endocrinology

Amsterdam, Netherlands
May 18-19, 2026

57th Annual Congress on Endocrinology and Diabetes Research

Aix-en-Provence, France

Lipid Metabolism Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in